ELA/APELA precursor cleaved by furin displays tumor suppressor function in renal cell carcinoma through mTORC1 activation
Author:
Funder
INSERM
SIRIC BRIO
La Ligue contre le cancer
Region Nouvelle Aquitaine
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://insight.jci.org/articles/view/129070/files/pdf
Reference57 articles.
1. Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration
2. Epidemiology and risk factors for kidney cancer
3. Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib
4. A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma;Sivanand;Sci Transl Med,2012
5. Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reciprocal Interactions Between Apelin and Noncoding RNAs in Cancer Progression;Cell Biochemistry and Function;2024-09-04
2. Apela promotes blood vessel regeneration and remodeling in zebrafish;Scientific Reports;2024-02-14
3. Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis;Cellular and Molecular Life Sciences;2023-12-13
4. Targeting the apelin system for the treatment of cardiovascular diseases;Cardiovascular Research;2023-11-13
5. Advances in the study of ELABELA in renal physiological functions and related diseases;Frontiers in Pharmacology;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3